YIH
LNAI

Y-Intercept (HK)’s Lunai Bioworks LNAI Stock Holding History

Y-Intercept (HK)’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-181
Closed -$4.19K – 1959
2025
Q2 		$4.19K Buy
+181
New +$5.05K ﹤0.01% 1587
2024
Q4 		– Sell
-155
Closed -$5.98K – 1577
2024
Q3 		$5.98K Buy
+155
New +$10.7K ﹤0.01% 1237
2024
Q2 		– Sell
-526
Closed -$111K – 1837
2024
Q1 		$111K Buy
526
+295
+128% +$79.6K 0.01% 1269
2023
Q4 		$58.6K Buy
+231
New +$63.3K 0.01% 1144
2023
Q3 		– Sell
-540
Closed -$24.5K – 1501
2023
Q2 		$24.5K Buy
+540
New +$41.4K ﹤0.01% 1214

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Y-Intercept (HK)'s LNAI Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 181 shares — an estimated $4.19K sold.

Y-Intercept (HK) first reported a position in LNAI in Q2 2023 and held it in 5 quarters. The position peaked at $111K in Q1 2024. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 181 Lunai Bioworks shares in Q3 2025, an estimated $4.19K.
  • Y-Intercept (HK) first reported a position in Lunai Bioworks in Q2 2023 and held it in 5 quarters.
  • Y-Intercept (HK)'s Lunai Bioworks position peaked at $111K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.